The Role of TLRs in Anti-cancer Immunity and Tumor Rejection

The Role of TLRs in Anti-cancer Immunity and Tumor Rejection

In recent years, a lot of scientific interest has focused on cancer immunotherapy. Although chronic inflammation has been described as one of the hallmarks of cancer, acute inflammation can actually trigger the immune system to fight diseases, including cancer. Toll-like receptor (TLR) ligands have...

Full description

Bibliographic Details
Main Authors: Zuzanna Urban-Wojciuk, Mohd M. Khan, Benjamin L. Oyler, Robin Fåhraeus, Natalia Marek-Trzonkowska, Aleksandra Nita-Lazar, Ted R. Hupp, David R. Goodlett
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Immunology
Subjects:
toll-like receptors
immuno-oncology
anti-cancer immunity
tumor rejection
immunotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02388/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.02388/full

Similar Items